Table 3.

Summarized rates of treatment for non-pregnancy in each investigation (%).

	Burch, 2012	Bartalena, 2015	Negro, 2016	Beshyah, 2017	Goichot, 2017	Wang, 2021
Region	North America	Europe	Italy	MENA	France	Mainland China
Respondents	730	147	947	352	263	756
ATD	53.9%	83.8%	77.1%	53%	91%	98.5%
MMI	83.5%	79.3%	97.7%	9%	-	96.1%
PTU	2.7%	2.9%	1.4%	5%	-	3.9%
Carbimazole	13.8%	17.9%	0.9%	86%	-	-
RAI	45.0%	14.1%	16.2%	37%	6.1%	1.3%
Thyroidectomy	0.7%	2.1%	4.5%	3%	2.9%	0.1%

ATD, anti-thyroid drug; MENA, Middle East and North Africa; MMI, methimazole; PTU, propylthiouracil; RAI, radioactive iodine.